Home
Search
Archive
Contact
RSS & alerts
Subscription
Current issue
Development of TLR9 agonists for cancer therapy
J. Clin. Invest.
Arthur M. Krieg, et al. 117:1184
doi:10.1172/JCI31414 [
Go to this article.
]
Table 1
Classes of CpG ODN